Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Timeframe for evaluation

<< Previous

Bullboard Posts

Next >>

Comment by NeilPaert74on Sep 04, 2020 5:51pm

233 Views

Post# 31514340

RE:RE:Timeframe for evaluation

skys1 wrote: I suspect positive news will come a few days before the AGM. They are managing the timeing of news, such as the release the Q financials after the market close on a Friday afternoon.
I wouldn't be surprised if they already have it.

I think Eoga sniffed it out a while back, somethin' formal with Roswell Park. Maybe some solid data and a RP paid for phase 1 on nsclc announced?

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network